Office deals: Swiss biopharma firm lands in Brickell as French ag processor exits for Coral Gables
A Swiss biopharmaceutical company will establish its U.S. headquarters in Miami’s Brickell, while a French agricultural firm is leaving the financial district for Coral Gables. Zug-based MoonLake Immunotherapeutics, which focuses on developing nanobody-based therapies for inflammatory skin and joint diseases, leased 13,500 square feet at Brickell Key Centre II, at 601 Brickell Key Drive, under a roughly 11-year term, according to the South Florida Business Journal. Meanwhile, Sucden Americas — part of Paris-based Sucden, a sugar, cocoa, coffee and other agricultural products process and delivery company — leased 7,700 square feet at 255 Alhambra Circle in Coral Gables under a […]This article originally appeared on The Real Deal. Click here to read the full story.
Recent Posts
“Ultrahazardous”: Neighboring condo building sues Swire, BG over Mandarin hotel implosion
Paterson Project Management, Kadima Developers secure $64M in construction financing for Broward projects amid selective lending market
Tricolor founder, accused of fraud, finds buyer for $22M Miami Beach condo
Where retail demand will reshape Wynwood after Ken Griffin’s $1B megadeal
Playboy to acquire Miami Beach hotel for private club as it plans move from LA
Related Group, BH, Pebb secure another $141M loan for Office Depot development site
Cain’s Jonathan Goldstein sees top Miami office rents reaching Manhattan levels
NAR adopts MLS policy changes on copyright, data use
South Florida Dirt: Who stands to win from the property tax cuts?
